The growth of New Haven’s biotech industry has prompted steady demand for new lab space in the backyard of Yale School of Medicine, pointing toward an economic growth opportunity creating thousands of high-paying jobs.
Alexion Pharmaceuticals, Inc. has completed its acquisition of Syntimmune.
Single-family homes are on the way out and commercial space could be in the mix at Great Pond Village, in a developer’s latest vision for a massive planned community in Windsor.
A Connecticut pharmaceutical company has announced it plans to lay off more than 200 employees in the coming weeks.
Alexion Pharmaceuticals Inc. reported second-quarter profit of $114.9 million and cut its expectations for net income this year.
